Literature DB >> 26819672

Probabilistic Approach to Generating MPOs and Its Application as a Scoring Function for CNS Drugs.

Hakan Gunaydin1.   

Abstract

Multiparameter optimization (MPO) scoring functions are popular tools for providing guidance on how to design desired molecules in medicinal chemistry. The utility of a new probabilistic MPO (pMPO) scoring function method and its application as a scoring function for CNS drugs are described in this letter. In this new approach, a minimal number of statistically determined empirical boundaries is combined with the probability distribution of the desired molecules to define desirability functions. This approach attempts to minimize the number of parameters that define MPO scores while maintaining a high level of predictive power. Results obtained from a test-set of orally approved drugs show that the pMPO approach described here can be used to separate desired molecules from undesired ones with accuracy comparable to a Bayesian model with the advantage of better human interpretability. The application of this pMPO approach for blood-brain barrier penetrant drugs is also described.

Entities:  

Keywords:  CNS; MPO; Multiparameter optimization

Year:  2015        PMID: 26819672      PMCID: PMC4716604          DOI: 10.1021/acsmedchemlett.5b00390

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  13 in total

Review 1.  Strategies to minimize CNS toxicity: in vitro high-throughput assays and computational modeling.

Authors:  Travis T Wager; Jennifer L Liras; Scot Mente; Patrick Trapa
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-03-29       Impact factor: 4.481

2.  Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.

Authors:  Travis T Wager; Xinjun Hou; Patrick R Verhoest; Anabella Villalobos
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

3.  Quantifying the chemical beauty of drugs.

Authors:  G Richard Bickerton; Gaia V Paolini; Jérémy Besnard; Sorel Muresan; Andrew L Hopkins
Journal:  Nat Chem       Date:  2012-01-24       Impact factor: 24.427

4.  Quantification and characterization of P-glycoprotein-substrate interactions.

Authors:  Ewa Gatlik-Landwojtowicz; Päivi Aänismaa; Anna Seelig
Journal:  Biochemistry       Date:  2006-03-07       Impact factor: 3.162

5.  Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide.

Authors:  Krzysztof Łabuzek; Dariusz Suchy; Bożena Gabryel; Anna Bielecka; Sebastian Liber; Bogusław Okopień
Journal:  Pharmacol Rep       Date:  2010 Sep-Oct       Impact factor: 3.024

Review 6.  Drug-like property concepts in pharmaceutical design.

Authors:  Li Di; Edward H Kerns; Guy T Carter
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 7.  CNS drug design: balancing physicochemical properties for optimal brain exposure.

Authors:  Zoran Rankovic
Journal:  J Med Chem       Date:  2015-01-06       Impact factor: 7.446

8.  Cardiac effects of antimalarial treatment with halofantrine.

Authors:  F Nosten; F O ter Kuile; C Luxemburger; C Woodrow; D E Kyle; T Chongsuphajaisiddhi; N J White
Journal:  Lancet       Date:  1993-04-24       Impact factor: 79.321

9.  De novo prediction of p-glycoprotein-mediated efflux liability for druglike compounds.

Authors:  Hakan Gunaydin; Matthew M Weiss; Yaxiong Sun
Journal:  ACS Med Chem Lett       Date:  2012-11-06       Impact factor: 4.345

10.  Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors.

Authors:  Anthony A Estrada; Zachary K Sweeney
Journal:  J Med Chem       Date:  2015-05-14       Impact factor: 7.446

View more
  6 in total

Review 1.  The medicinal chemistry of mitochondrial dysfunction: a critical overview of efforts to modulate mitochondrial health.

Authors:  Maximillian Taro William Lee; William Mahy; Mark David Rackham
Journal:  RSC Med Chem       Date:  2021-06-04

Review 2.  Essential Medicinal Chemistry of Essential Medicines.

Authors:  Marta Serafini; Sarah Cargnin; Alberto Massarotti; Tracey Pirali; Armando A Genazzani
Journal:  J Med Chem       Date:  2020-05-12       Impact factor: 7.446

3.  AB-DB: Force-Field parameters, MD trajectories, QM-based data, and Descriptors of Antimicrobials.

Authors:  Silvia Gervasoni; Giuliano Malloci; Andrea Bosin; Attilio V Vargiu; Helen I Zgurskaya; Paolo Ruggerone
Journal:  Sci Data       Date:  2022-04-01       Impact factor: 6.444

Review 4.  Defining Levels of Automated Chemical Design.

Authors:  Brian Goldman; Steven Kearnes; Trevor Kramer; Patrick Riley; W Patrick Walters
Journal:  J Med Chem       Date:  2022-05-05       Impact factor: 8.039

Review 5.  Carboxylic Acid Counterions in FDA-Approved Pharmaceutical Salts.

Authors:  Sonali S Bharate
Journal:  Pharm Res       Date:  2021-07-23       Impact factor: 4.200

6.  Discovery of Arylsulfonamide Nav1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity Profile.

Authors:  Anthony J Roecker; Mark E Layton; Joseph E Pero; Michael J Kelly; Thomas J Greshock; Richard L Kraus; Yuxing Li; Rebecca Klein; Michelle Clements; Christopher Daley; Aneta Jovanovska; Jeanine E Ballard; Deping Wang; Fuqiang Zhao; Andrew P J Brunskill; Xuanjia Peng; Xiu Wang; Haiyan Sun; Andrea K Houghton; Christopher S Burgey
Journal:  ACS Med Chem Lett       Date:  2021-06-01       Impact factor: 4.632

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.